Best Companies In San Diego, CA

We are a leading national insurance carrier offering a range of products for businesses, including workers' compensation and earthquake, as well as automobile coverage for individuals. Follow us here for company updates, career opportunities and to lea...

MedImpact is a pharmacy benefit manager who works with your health plan to get you the medication you need. Our goal is to make it as easy as possible for you. We work with your health plan and pharmacy to provide essential information about your medic...

SDG&E is a regulated public utility that provides energy service to 3.4 million people through 1.4 million electric meters and 860,000 natural gas meters in San Diego and southern Orange counties. their service area spans 4,100 square miles.

NuVasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the 4th largest player in the $8.2 billion global spine market. NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess , a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform's lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF , NuVasive has built an entire spine franchise. With over 80 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus and dedication to outstanding service levels supported by a culture of Absolute Responsiveness .

Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, CA. Arena Pharmaceuticals is focused on delivering novel, transformational medicines with optimized pharmacology and pharmacokinetics to patients globally. Arena's proprietary pipeline includes multiple potentially first- or best-in-class programs with broad clinical utility.

Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the insulin, cancer, dermatology and drug delivery markets. The company's product portfolio is based primarily on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Halozyme's Enhanze(TM) technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. The company has key partnerships with Roche, Baxter, ViroPharma and Intrexon to apply Enhanze technology to therapeutic biologics including Herceptin , MabThera , immunoglobulin, Cinryze and alpha 1-antitrypsin. Halozyme's Ultrafast Insulin program combines its rHuPH20 enzyme with mealtime insulins, which may produce more rapid absorption, faster action, and improved glycemic control. The product candidates in Halozyme's pipeline target multiple areas of significant unmet medical need.

Founded in 1951, Cubic began as a small electronics company operating from a modest San Diego storefront, eventually developing equipment for precision distance measuring, aerial photo mapping and surveying. Guided by its mission to provide its global customers with innovative, mission-critical solutions to reduce congestion and increase operational readiness and effectiveness through superior situational understanding, Cubic has continued to lead the field in providing quality services to its customers.

Cumming Corporation is a construction company offering project management and cost consulting services.

Illumina is dedicated to advancing human health by unlocking the power of the genome. The company provides sequencing and array-based solutions for genetic analysis, and serve as tools for disease research, drug development, and the development of molecular tests in the clinic. Illumina's solutions are used in the life sciences, oncology, reproductive health, agriculture, forensic genomics, and other areas. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California. The company employs over 6000 employees.

MatrixCare is the complete solution for growing organizations that need to successfully manage risk in care delivery across the LTPAC spectrum. Trusted by more than 13,000 facility-based care settings and more than 2,500 home care, home health and hospice organizations, MatrixCare's solutions help ACOs, skilled nursing and senior living providers, life plan communities (CCRCs), and home health organizations to connect, collaborate and prosper as they migrate to a fee-for-value healthcare system.

Robbins Geller Rudman & Dowd LLP (“Robbins Geller” or the “Firm”) specializes in complex litigation emphasizing securities, corporate mergers and acquisitions, shareholder derivative, whistleblower, antitrust, consumer and insurance class actions. The Firm's unparalleled experience and capabilities in these fields are based on the talents of its attorneys, who have successfully prosecuted thousands of class action lawsuits. The Firm is widely recognized as a leading law firm worldwide. Judges have described Robbins Geller as one of the most formidable securities law firms in the country. With 200 lawyers in 10 offices nationwide, the Firm has the resources, experience and tenacity to achieve superior results. Robbins Geller attorneys have shaped the law in the area of securities litigation and shareholder rights, and have recovered tens of billions of dollars on behalf of the Firm's clients.

PriceSmart, Inc. (NASDAQ: PSMT) is the largest operator of membership warehouse clubs in Central America and the Caribbean, and has recently entered the South American region with clubs in Colombia. We serve over 1 million cardholders at 33 owned and operated warehouse clubs in 12 countries and one U.S. territory. PriceSmart was pioneered by Sol and Robert Price, founders of The Price Club; Robert Price is Chairman of the Board.

Lytx, Inc. develops video-based driver safety and fleet management solutions. The company offers DriveCam that identifies, prioritizes, and corrects the causes of poor driving to set standards for driver safety needs; RAIR web-based suite of compliance services that helps carriers manage CSA, hours-of-service, driver vehicle inspection report, and driver qualification aspects; a fleet tracking solution; and a fuel management solution. The company provides its solutions to trucking and transportation organizations, and their drivers; and the construction, distribution, government, transit, utility, waste and environmental, and commercial markets. It serves customers in the United States and internationally. The company was formerly known as DriveCam, Inc. and changed its name to Lytx, Inc. in November 2013. It was founded in 1998 and is based in San Diego, California.

To provide the security industry with professional officers and services that are expected by our clients.

Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML. Ambit is developing AC220 in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity's vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.

We provide attorney services and total document solutions to clients across California. We work both on-site and off-site to meet our clients needs.

Sempra Energy was created in 1998 by a merger of parent companies of two long-established, and highly respected, investor-owned utilities with rich histories dating back more than a century. Sempra Energy was founded to capitalize on new opportunities in competitive energy markets. The company's ongoing focus is to enhance shareholder value and meet customer needs by sustaining the financial strength, operational flexibility and skilled workforce needed to succeed in rapidly changing market conditions. Sempra Energy is a Fortune 500 energy services company, based in San Diego, Calif., that combines deep industry expertise with rigorous risk management to deliver superior shareholder returns. In 2013, Sempra Energy produced revenues of approximately $10.5 billion.